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A novel peptidyl-prolyl cishrans isomerase was isolated from Escherichia coli cell extract and characterized partially. Determination of the molecular 
mass by electrospray mass spectrometry indicated a protein of 10102 + 2 Da, smaller than cyclophihns or FK506 binding proteins currently known. 
The specificity constant kJ& determined with Succinyl-Ala-Xaa-Pro-Phe-4-nitroanilide (Xaa = Leu) had a value comparable to those from 
cyclophilins from the same organism. However, the pattern of subsite specificity (Xaa = Gly, Ala, Val, Ile, Leu, Phe, Trp, His, Lys and Glu) was 
reminiscent of FK506 binding peptidyl-prolyl cishrans isomerases. The enzyme activity was not inhibited by cyclosporin A or FK506 at inhibitor 
concentrations of c 5 PM, concentrations that affect most bacterial peptidyl-prolyl cisltrans isomerases. Computer-assisted analysis of 21 amino acid 
residues of the N-terminus determined by Edman degradation revealed no homology to known peptidyl-prolyl cisltrans isomerases. 
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1. Introduction 
Peptidyl-prolyl &&runs isomerases (PPIases; EC 
5.2.1.8) catalyse the cisltrans isomerization of the pepti- 
dyl-prolyl peptide bond in oligopeptides and are thought 
to be able to accelerate slow steps in protein refolding 
that are limited in rate by cisltrans isomerizations of 
peptidyl-propyl peptide bonds [l-3]. PPIases occur in 
mammals as well as in plants, fungi and bacteria. Per- 
haps they control the binary cisltruns switch of prolyl 
peptide bonds at various conformational states of the 
polypeptide chains within the cell [4]. Currently they are 
divided into two families, cyclophilins (Cyp) and FK506 
binding proteins (FKBP), which have little if any amino 
acid sequence similarity to each other [5]. However, 
within each family a core containing highly conserved 
amino acids exists which has been transmitted from 
prokaryotes to eukaryotes during evolution [6]. Typi- 
cally, the core includes about 80 and 100 residues for 
FKBPs and cyclophilins, respectively. Cyclophilins from 
all sources bind tightly (Ki << 0.1 mM) to the immuno- 
suppressive undecapeptide cyclosporin A with a time- 
dependent loss of enzymatic activity. A related reversible 
reaction occurs between FKBPs and the immunosup- 
pressive macrolides FK506 and rapamycin (Ki c 1 PM). 
The inhibition of PPIase activity, however, is not respon- 
sible for the suppression of the clonal expansion of 
T-cells induced by these effecters [7,8]. Instead, PPIase 
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activity is important for protein folding and trafficking 
[9-l 13. 
As much as 9 different PPIases were detected and 
characterized in human cells until now. This contrasts 
with only two cyclophilins expressed in E. coli, one of 
which is found in the cytosol and one in the periplasmic 
space [12-141. FKBP-like proteins have not yet been de- 
tected in this organism although an open reading frame 
(ORF) in the LspA-DapB intergenic region exists which 
may code for a 16.1 kDa protein [15], showing 33% 
identity to the cytosolic 12 kDa human FKBP (human 
FKBPl2cy) [6]. Furthermore, an E. coli sequence of 200 
amino acids in length was reported by Wuelfing and 
Plueckthun (EMBL:S33444) that shows a N-terminal re- 
gion with clusters of residues found to be fully conserved 
throughout the FKBP family. C-terminally a histidine- 
rich region, proposed to be a metal ion binding motif is 
linked to the FKBP domain. However, there is no infor- 
mation about an enzymatic activity of this protein. 
In the pathogenic Gram-negative bacterium Le- 
gionella pneumophila, the causative agent of Legion- 
naires disease, the FKBP-homologous Mip protein 
(25 kDa) has been characterized as a FK506-inhibitable 
PPI-ase [16]. From the same organism a cyclophilin of 
18 kDa has been isolated, sequenced and tested for cata- 
lytic function in prolyl cisltruns isomerization [17] indi- 
cating that bacteria may simultaneously express both 
types of PPIase activity. Cyclophilins also occur in Bucil- 
lus subtilis [ 131 and Streptomyces chrysomallus [ 141, while 
FKBPs have been found in Streptomyces chrysomallus 
[20], Neisseria meningitidis [21] and Chlamydia trachoma- 
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tis [22]. In addition some ORFs were identified coding 
for proteins with some similarity to the core region of 
cyclophilins or FKBPs in Salmonella typhimurium [23], 
Synechococcus sp. [24], and Pseudomonas aeruginosa[25]. 
The present paper describes the isolation and prelimi- 
nary characterisation of a new PPIase with an exception- 
ally low molecular mass from E. coli. 
2. Experimental 
2.1. Materials 
4-(2-hydroxyethyl)-l-Piperazineethanesulphonic acid (HEPES) and 
N-tris(hydroxynrethyl)-methylglycine (Tricine) were obtained from 
Serva. Heidelberg: 1.4-Dithiothreitol (DTI? was from Roth. 
Karl&he; chymo&sin, Fractogel EMD DEAE-650(M), Fractogel 
EMD SOr-650(M) Fractogel TSK AF-Blue and Benzon Nuclease solu- 
tion (Benzonase, 25 U&l) were purchased from Merck, Darmstadt; the 
HPLC column (300~C.,-5 ,um, 50 x 3 mm) was from Macherey-Nagel, 
Diiren; the HiLoad 16/60 Superdex 75 column was obtained from 
Pharmacia LKB, Uppsala and all substrates for the PPIase activity 
assay were purchased from Bachem, Heidelberg. 
2.2. Purification 
E. coli K12 cells were grown overnight at 37°C in LB-medium, 
containing sodium chloride (5 g/l), yeast extract (10 g/l) and tryptone 
(5 g/l). The cells were harvested by centrifugation at 4’C for 10 min at 
6,000 x g in a Centricon T-324 centrifuge. The pellet was resuspended 
in 20 mM Tricine buffer, pH 8.5 (buffer A) and the cells were disrupted 
in a SLM Aminco FRENCH pressure cell with 20,000 psi. The cell 
lysate was stirred for 15 min at 25°C with 0.1% (vol/vol) Benzonase. 
The cell debris were removed by centrifugation at 4°C for 30 min at 
20,000 g in a Beckman L8 60M ultracentrifuge. An equal volume of 
buffer A was added to the supematant, he pH was adjusted to pH 8.5 
and the protein solution was passed through a Fractogel EMD DEAE- 
650(M) column (2.5 x 20 cm). The flow-through fractions were col- 
lected and applied to a Fractogel TSK AF-Blue column (1 x 5 cm), 
equilibrated -with buffer A. Using a linear gradient of O-2 M KC1 in 
buffer A, PPIase-active fractions were eluted at KC1 concentrations of 
100 to 150 mM. The active fractions were concentrated with a Filtron 
OMEGACELL, 5,000 Da and applied to a HiLoad 16/60 Superdex 75 
gel filtration column equilibrated with 10 mM HEPES buffer, pH 7.8, 
containing 150 mM KC1 and 0.5 mM DTT (buffer B). PPIase-active 
fractions were pooled and dialysed against 10 mM HEPES buffer, pH 
7.8 (buffer C). Final purification to homogeneity was obtained by 
cation-exchange chromatography on a Fractogel EMD SO,-650(M) 
column (1 x 2 cm) equilibrated with buffer C. PPIase-active fractions 
were eluted using a linear gradient of O-2 M NaCl in buffer C at 
approximately 200 mM NaCl. 
2.3. PPIase assay, substrate specl$city and inhibition studies 
PPIase activity was determined using a protease-coupled assay with 
chymotrypsin and the substrate Succinyl-Ala-Phe-Pro-Phe-4-ni- 
troanilide [16] in 0.035 M HEPES buffer, pH 7.8, at 10°C. Stock 
solutions of substrates were made in dimethylsulfoxide. The reaction 
was started by the addition of 2 ~1 substrate solution to the reaction 
mixture. For inhibition studies the PPIase assay was carried out with 
addition of FK506 or cyclosporin A from a stock solution in 50% 
(vol/vol) aqueous ethanol. A Hewlett Packard 8452 diode array UV/ 
VIS spectrophotometer was used for monitoring the time course of the 
reaction. The obtained first-order kinetics can be described by the rate 
equation v = kob. [cis]; /cob, =k, + km. ([cis] is the time-dependent con- 
centration of the cis conformer, k, is the uncatalysed, /c, is the PPIase- 
catalysed cis to tram interconversion of the substrate). The specificity 
constant k,,lXa, was obtained from the equation k_JK,,, = (kob - k,)/ 
[PPIasel,ti assuming that the entire amount of the pure enzyme protein 
represents catalytically active molecules. For determination of the vol- 
ume-dependent activity of crude enzyme fractions in the assay we used 
arbitrary units, AU = (k,dk,) -1. Protein concentration was deter- 
mined with the Bradford assay [26] using a bovine serum albumin 
standard. 
2.4. Determination of the N-terminal amino acid sequence and data 
analysis 
Protein from 400 ~1 of the solution eluted from the Fractogel EMD 
SO,-650(M) column was blotted on ProSpin-PVDF membrane (Ap- 
plied Biosystems Inc.) with centrifugation at 5,000 x g. After rinsing the 
membrane with methanol/water 1:5 (vol/vol) the protein was sequenced 
on an Applied Biosystems gas-phase sequencer modul470A. 
In order to achieve optimal alignment of the resulting N-terminal 
part of the amino acid sequence, the program BESTFIT (University of 
Wisconsin Genetics Computer Group package) for pairwise homology 
comparison was used. Cyclophilin and FKBP sequences were tak- 
en from Protein Identification Resource release 37.x and Swissprot re- 
lease 25.0. Data base searches were performed using the program 
FASTA. 
2.5. Determination of the molecular mass 
A 15 pg protein sample eluted from the Fractogel EMD SO, column 
was concentrated, desalted and transferred into a volatile solvent by 
means of narrowbore reversed-phase HPLC. Portions of 1 ml were 
loaded on a 50 x 3 mm C., column equilibrated with 0.1% aqueous 
trifluoroacetic acid. The protein was eluted with a gradient of 0 to 60% 
a&on&rile in 0.1% triiluoroacetic acid within 12 min at a flow rate of 
1 ml/mm The eluted enzyme was still active. 
Molecular mass was determined by electrospray MS on a VG BIO-Q 
(Fisons Instruments), consisting of an electrospray ion source followed 
by a triple quadrupole mass analyser with a mass range of 4000. An 
aliquot of 5 ~1 of the HPLC-purified protein solution was injected 
directly into the electrospray device by way of a loop injector (Rheo- 
dyne 5717) at a solvent (acetonitrile/water 1:1 (vol/vol), 1% formic acid) 
flow rate of 4 pl/min (pump HP 1050). Scanning was performed from 
m/z 500 to m/z 1300 in 10 s and this mass scale was calibrated using 
horse heart myoglobin. 
3. Results and discussion 
A typical preparation was started from a 10 1 over- 
night culture of E. coli cells. After cell disruption and 
centrifugation 2.7 g of protein were obtained. A cy- 
closporin A-insensitive PPIase activity could be demon- 
strated only after passage of the protein through Fracto- 
gel EMD DEAE-650(M) and the Fractogel TSK AF- 
Blue column. During earlier stages in purification the 
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Fig. 1. Elution profile of HiLoad 16/60 Superdex 75 gel filtration of E. 
coli proteins desorbed from a Fractogel TSK AF-Blue column. The 
active fractions received from the Fractogel TSK AF-Blue column were 
concentrated. Aliquots of 1 ml were loaded onto a gel filtration column, 
equilibrated with 10 mM HEPES buffer, pH 7.8, containing 150 mM 
KC1 and 0.5 mM D’IT. The separation was done at a flow rate of 1 
ml/mm. The column was calibrated with bovine serum albumin (68000 
Da), ovalbumin (45000 Da), chymotrypsinogen A (25000 Da) and cyto- 
chrome c (12500 Da). PPIase activity (A); Absorbance at 280 nm (0). 
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Fig. 2. SDS-PAGE of puritied E. coli 10.1 kDa PPIase. Electrophero- 
gram of a silver stained SDS-~lyac~~de gel (17.5% acrylamide). 
Lanes 1 and 3 (molecular mass markers}: soybean trypsin inhibitor 
(21000 Da), cytochrome c (12500 Da) and aprotinin (6500 Da); lane 2, 
0.07 @g E coli 10.1 kDa PPIase. 
minor enzymatic activity signaling the new PPIase was 
obscured by enzyme activity resulting from the bulk of 
cyclophilins occurring in E. coli cells. This also prevented 
the calculation of the yield of the purification procedure. 
Gel filtration of the PPIase resulted in an active protein 
peak with a retention time corresponding to a molecular 
mass of about 10 kDa (Fig. 1). In the next portion 
step nearly pure protein was obtained using a cation- 
exchange column. The protein was analysed by SDS- 
PAGE (17.5% acrylamide). The silver-stained gel 
showed a single band with an apparent molecular mass 
of approximately 8 kDa (Fig. 2). The absence of other 
bands on a heavily overloaded polyacrylamide gel con- 
firmed that the PPIase activity in the enzyme assays orig- 
inated from the 8 kDa protein. The final yield was 18 pug 
pure enzyme. 
The accurate molecular mass of the novel PPIase was 
determined by electrospray ionisation mass spectrome- 
try after a tinal pupation step on reversed-phase 
HPLC. The measurement indicated a protein with a mo- 
lecular mass of 10101 i: 2 Da (Fig. 3). This value does 
not correspond to any of the known E. coli PPIases. All 
of them, the cytoplasmic (18.2 kDa) and the mature 
periplasmic cyclophilin (18.1 kDa) as well as the FKBP- 
like histidine-rich protein (21.3 kDa) and the ORF en- 
coding for a PPIase-related protein (16.1 kDa) consider- 
ably exceed this value. In comparison to human FKBP12 
(I 1824 Da; 107 amino acid residues) the smallest PPIase 
known to date, the 10.1 kDa E. coli PPIase may be 
considerably shorter than 100 amino acids. 
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Until now it is not known if the 10.1 kDa enzyme 
represents a proteolytic fragment of a more extended 
polypeptide chain. 
The first 21 amino acid residues found by Edman 
degradation of the new PPIase represent 22% of the mo- 
lecular mass of the entire enzyme (Fig. 4). Screening of 
the Pir, Mipsown and Swissprot data collections with the 
FASTA program did not reveal any convincing similar- 
ity to this novel sequence. Fig. 4 shows that only weak 
s~ila~ties can be detected by pairwise comparisons to 
known PPIase sequences with the BESTFIT program. 
Except for a single residue (Leu-96) in FKBP12cy the 
amino acids possessing a certain degree of similarity in 
the matched sequences do not include those conserved 
amino acids thought to be responsible for enzymatic 
activity. Thus, the new PPIase is not a truncated form of 
cyclophilin or FKBP FKBPs as well as cyclophilins pu- 
rified from mammalian species can be inhibited by the 
respective immunosuppressive drug in the nanomolar 
range 1271, whereas the E. co& cyclophilins are lOOO-fold 






Fig. 3. Electrospray ionization mass spectrum of E. coli 10.1 kDa 
PPIase. The spectnun (B) was received from deconvolution of eight 
peaks from the mass/charge spectrum (A). 
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Fig. 4. The NH,-terminal 21 amino acids of the E. coli 10.1 kDa PPIase 
aligned with the most similar stretches from E. coli cyclophilins, an 
ORF with FKBP homology from the same organism and human 
FKBPl2cy. Identity and similarity were calculated by pairwise compar- 
ison using the program BESTFIT. The percent similarity (E. coli 
Cyp2lperi, 50.0; E. coli Cypl8cy, 47.6; E. coli 16.lORF, 60.0; human 
FKBPl2cy, 38.8) and the percent identy (E. coli Cyp2lperi, 20.0; E. coli 
Cypllcy, 19.0; E. coli 16.lORF, 15.0; human FKBPl2cy, 16.7) were 
calculated. Strongly conserved amino acids in the cyclophilins and 
FKBPs are shown in bold letters. 
absence of the tryptophan residue in position 121 which 
has been shown to be important for the binding of this 
cyclopeptide [28]. When exposed to concentrations of 
either 5 PM FK506 or 5 PM cyclosporin A, there is no 
indication for inhibition of the enzymatic activity of the 
E. coli 10.1 kDa PPIase. 
Despite its insensitivity to micromolar concentrations 
of FK506, the E. coli 10.1 kDa PPIase shows the typical 
pattern of substrate specificity of FKBPs as indicated in 
Table 1. The E. coli 10.1 kDa PPIase prefers amino acid 
residues with hydrophobic side chains like leucine and 
Table 1 
Substrate specificity of the E. coli 10.1 kDa PPIase compared with 
CypZlperi (E. coZz> [14] and human recombinant FKBPl2cy 
Xaa E. coli 21 peri E. coli 10.1 kDa 
PPIase 
rhFKBPl2cy 
Gl Y 93 0 0 
Ala 345 60 12 
Val nt 32 48 
Ile nt 40 88 
Leu 120 150 145 
Phe 100 100 100 
Trp nt 44 19 
His 55 34 4 
LYS 17 30 4 
Glu 86 15 0 
The relative specificity constants /c&G for the substrates of the type 
Succinyl-Ala-Xaa-Pro-Phe-4~nitroanilide are shown. Succinyl-Ala- 
Phe-Pro-Phe+nitroanilide was set to 100%. Measurements were car- 
ried out in 35 mM HEPES buffer, pH 7.8, at 10°C. 
phenylalanine in the Pi-position of the peptide substrates 
[29]. The unusually high PPIase activity for the substrate 
with an alanyl residue in this position allowed to differ- 
entiate the enzyme from FKBPs. 
The E. coli 10.1 kDa PPIase showed a specificity con- 
stant k,,,/K, of 1.69 . lo7 M-i . s-l for the substrate suc- 
cinyl-Ala-Leu-Pro-Phe-4-nitroanilide. This value consid- 
erably exceeds enzymatic activities published for FKBPs 
and corresponds to the highest catalytic constants meas- 
ured for the E. coli cyclophilins [ 171. 
In conclusion, the finding of a previously undetected 
10.1 kDa PPIase supplements the equipment of E. coli 
with PPIases. Three proteins have now been established 
for this organism differing in subsite specificity, inhibitor 
sensitivity, molecular mass and amino acid sequence. 
The unusually small enzyme characterized in the pres- 
ent report indicates the existence of a third family of PPI- 
ases in E. coli, unrelated to the previously known en- 
zymes. 
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